Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update
10:00am, Monday, 17'th Apr 2023
Moderna (NASDAQ: MRNA ) stock is sinking this morning despite releasing positive data about its cancer vaccine yesterday. Specifically, when used in combination with Merck's (NYSE: MRK ) drug, Keytrud
This Prediction May Completely Change Your Opinion of Moderna
05:30am, Monday, 17'th Apr 2023
Investors have worried about declining coronavirus vaccine revenue at Moderna. The company has many potential products in the pipeline though -- and a path to revenue growth.
Wall Street analysts are bullish on Moderna stock price: should you?
03:55am, Monday, 17'th Apr 2023
Moderna (NASDAQ: MRNA) stock price will be in the spotlight on Monday after the company announced important outcome of its skin cancer vaccine. The shares, which closed at $157 on Friday, are expected
Moderna, Merck combo cancer-vaccine treatment shows ‘significant' promise
05:21pm, Sunday, 16'th Apr 2023
A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%, the drug makers said Sunday.
Moderna Shows Progress Toward Cancer Vaccines
11:00am, Sunday, 16'th Apr 2023
An mRNA shot helped prevent relapse in high-risk melanoma patients.
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
10:40am, Friday, 14'th Apr 2023
Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.
We have seen a host of companies such as Moderna Inc and Legend Biotech Corp grow to join the major league of biotech companies. But how do you spot the rookie in the minors ready to make the step up
Final Trades: Vertex, ConocoPhillips, Moderna & more
03:05pm, Wednesday, 12'th Apr 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab Setback
12:55pm, Wednesday, 12'th Apr 2023
Moderna (MRNA) expects $8-$15 billion in product revenues from the respiratory vaccine by 2027. Its first influenza vaccine candidate failed to meet the statistical threshold for early success.
Moderna stock drops on mixed data tied to flu vaccine approval
04:20pm, Tuesday, 11'th Apr 2023
The Yahoo Finance Live team discusses the three stocks to watch, including Moderna, whose stock fell after a release of contrary data related to their flu vaccine.
Moderna withholds declaring ‘early success' for its Influenza vaccine
11:54am, Tuesday, 11'th Apr 2023
Shares of Moderna Inc (NASDAQ: MRNA) are trading down on Tuesday after the biotechnology company said it did not have enough data to declare “early success” for its Influenza vaccine.
Moderna says there are not enough cases to declare early success for its mRNA flu vaccine
11:51am, Tuesday, 11'th Apr 2023
CNBC's Meg Tirrell reports on news from Moderna that it will delay results from its flu vaccine trials.
Moderna Stock Falls After Vaccines Update
11:48am, Tuesday, 11'th Apr 2023
The biotech company is working on new drugs for Lyme disease and Covid-19 as it prepares to roll out six new products with “sizable markets.”
Could Moderna Become a Warren Buffett Stock?
10:07am, Tuesday, 11'th Apr 2023
Warren Buffett doesn't typically invest in biopharma stocks. Moderna has programs that could eventually make it more appealing to him.
Moderna stock slides following experimental flu vaccine setback
09:59am, Tuesday, 11'th Apr 2023
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the decline in stock for Moderna.
